The Readout

Moderna’s patent problems & clocking the CRISPR race

By Damian Garde @damiangarde and Meghana Keshavan @megkesh

May 17, 2017

Alex Hogan/STAT

The Readout for May 17, 2017

About the Authors

Damian Garde
National Biotech Reporter
Damian covers biotech and writes The Readout newsletter.
Meghana Keshavan
Biotech Correspondent
Meghana covers biotech and writes The Readout newsletter.
Trending
Gottlieb Generic Drugs
Frustrated at the pace of biosimilar development, FDA yanks…
Frustrated at the pace of biosimilar development, FDA yanks a draft guidance
FDA campus
White House proposes a narrowing of FDA’s mission —…
White House proposes a narrowing of FDA’s mission — and a new name
Denise Faustman
Controversial researcher’s diabetes vaccine causes improvement in small study
Controversial researcher’s diabetes vaccine causes improvement in small study
Recommended
Theranos’s defense strategy, ‘right-to-try’ profiteers, & putting the ‘F’…
Theranos’s defense strategy, ‘right-to-try’ profiteers, & putting the ‘F’ in ‘FDA’
The READOUT
‘Right-to-try’ as a business model & Wave’s DMD crash
‘Right-to-try’ as a business model & Wave’s DMD crash
The READOUT
Sarepta’s big day & Theranos’ last defender
Sarepta’s big day & Theranos’ last defender

Recommended Stories

The Readout

Theranos’s defense strategy, ‘right-to-try’ profiteers, & putting the ‘F’ in ‘FDA’

By Damian Garde

The READOUT
The Readout

‘Right-to-try’ as a business model & Wave’s DMD crash

By Damian Garde

The READOUT
The Readout

Sarepta’s big day & Theranos’ last defender

By Damian Garde

The READOUT
The Readout

The future of Theranos & pregaming Sarepta’s big day

By Damian Garde and Meghana Keshavan

The READOUT
The Readout

China’s snapping up biotech talent & an analyst gets prison time

By Damian Garde and Meghana Keshavan

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy